insights_auto
Outlook: 72.7% bullish·4.5% bearish
Go to analysischevron_right
SIG:ASX
Sigma Healthcare Ltd
A$2.74
arrow_downward
-0.36%(-0.0100) 1D
Oct 22, 4:10:29 PM GMT+11 · AUD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SIG...
Open
A$2.72
High
A$2.77
Low
A$2.72
Mkt. cap
31.63B
Avg. vol.
18.59M
Volume
16.92M
Dividend
1.46%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
44.47
52-wk high
A$3.20
52-wk low
A$2.47
EPS
A$0.06
Shares outstanding
11.54B
No. of employees
156
Open
A$2.72
High
A$2.77
Low
A$2.72
Mkt. cap
31.63B
Avg. vol.
18.59M
Volume
16.92M
Dividend
1.46%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
44.47
52-wk high
A$3.20
52-wk low
A$2.47
EPS
A$0.06
Shares outstanding
11.54B
No. of employees
156
News stories
From web sources and news partners
Rask Media
·
8 hours ago
Sigma Healthcare (ASX:SIG) share price in focus on FY27 sales update
TheBull.com.au
·
22 hours ago
Sigma Healthcare Shares Sit Between Two Key Levels, In Battle For Direction
Profile
Sigma Healthcare Limited is an Australian, ASX-listed company with a focus on the pharmacy industry. The company has pharmacy operations in retail, wholesale and distribution. From its head office in Preston, Victoria, Sigma manages over 1,200 branded and independent pharmacies. Sigma Healthcare owns Australian retail pharmacy brands: Amcal, Chemist Warehouse and Discount Drug Stores. The company also has a presence in the hospital pharmacy services, contract logistics, dose administration aids and other healthcare service adjacencies. Wikipedia
About Sigma Healthcare Ltd
CEOMark Hooper | Vikesh Ramsunder
Employees156
Founded1912
HeadquartersClayton, Victoria, Australia
SectorHealth care provider
Websitesigmahealthcare.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in AUD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.75B | 2.75B | 2.66B | 2.66B |
Cost of goods sold | 2.25B | 2.25B | 2.19B | 2.19B |
Cost of revenue | 2.25B | 2.25B | 2.19B | 2.19B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 235.05M | 235.05M | 247.36M | 247.36M |
Operating expense | 235.05M | 235.05M | 247.36M | 247.36M |
Total operating expenses | 2.49B | 2.49B | 2.44B | 2.44B |
Operating income | 268.85M | 268.85M | 227.18M | 227.18M |
Other non operating income | 4.89M | 4.89M | 12.24M | 12.24M |
EBT including unusual items | 268.48M | 268.48M | 234.05M | 234.05M |
EBT excluding unusual items | 268.48M | 268.48M | 234.05M | 234.05M |
Income tax expense | 78.96M | 78.96M | 69.25M | 69.25M |
Effective tax rate | 29.41% | 29.41% | 29.59% | 29.59% |
Other operating expenses | - | - | - | - |
Net income | 189.91M | 189.91M | 164.68M | 164.68M |
Net profit margin | 6.90% | 6.90% | 6.18% | 6.18% |
Earnings per share | - | - | - | - |
Interest and investment income | - | - | 27.51M | 27.51M |
Interest expense | -13.84M | -13.84M | -43.27M | -43.27M |
Net interest expenses | -13.84M | -13.84M | -15.76M | -15.76M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 280.19M | 280.19M | 238.75M | 238.75M |
Gain or loss from assets sale | - | - | - | - |